autologous tumor lysate (TL) + yeast cell wall particles (YCWP) + dendritic cells (DC) vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for autologous tumor lysate (TL) + yeast cell wall particles (YCWP) + dendritic cells (DC) vaccine, covering 2024-03-12 to 2024-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease. [Phase 1, Phase 2]